Clinical and Translational Science Institute

Alejandro Hoberman in a grey suit and blue shirt
A trial led by Alejandro Hoberman and published in the New England Journal of Medicine found no long-term benefit for tubes over antibiotics for childhood ear infections.
Esa Davis in a red and blue shirt in front of a plant
Esa Davis, associate professor of medicine and clinical and translational science, has been appointed to the national panel of experts tasked with making evidence-based recommendations about clinical preventive services and priorities for future study.
A person in a face mask and a white shirt holds a model in a gloved hand
Research published today in Science describes a new method to extract tiny but extremely powerful antibody fragments from llamas, which could then be fashioned into inhalable therapeutics for COVID-19. Tune in today at 3 p.m. EST for a press conference on the findings.
A woman in glasses and a black top holds a ear-shaped device to her head
It’s only fair that the Pitt Innovation Challenge would itself need to innovate. Find out which projects won this year’s competition—which awarded nearly $500,000—and how participants adjusted to a virtual event.
A depiction of the coronavirus
The Clinical and Translational Science Institute at the University of Pittsburgh has awarded $900,000 to 17 studies to address different aspects of the COVID-19 pandemic.
The CyteSolutions Lens
Dry eye affects millions of Americans a year, but available treatments can require continuous application. A Pitt bioengineering student and an eye doctor with the School of Medicine make up part of a team that invented a more efficient and sustained treatment delivery method.
Massart standing in a green space between a couple of brick buildings. She's wearing a black dress with three-quarter-length arms and a blue shawl, and has her arms crossed over her chest.
With the advent of direct-to-consumer genetic testing, patients are showing up at doctors’ offices with big questions about their genes. Physicians, however, aren’t usually trained to answer them. Enter Mylynda Massart and others at Pitt.